悦康药业跌2.22%，成交额5073.78万元，主力资金净流出316.76万元

Core Viewpoint - Yuyuan Pharmaceutical's stock price has shown significant volatility, with a year-to-date increase of 111.03%, but a recent decline of 8.04% over the past five trading days [2]. Group 1: Stock Performance - As of August 22, Yuyuan Pharmaceutical's stock price was 30.41 CNY per share, with a market capitalization of 13.684 billion CNY [1]. - The stock has experienced a 2.22% drop in intraday trading on August 22, with a trading volume of 50.738 million CNY and a turnover rate of 0.37% [1]. - The stock has been on the龙虎榜 three times this year, with the most recent net purchase of 171 million CNY on July 1, accounting for 41.87% of total trading volume [2]. Group 2: Financial Performance - For the first quarter of 2025, Yuyuan Pharmaceutical reported a revenue of 577 million CNY, representing a year-on-year decrease of 40.35% [2]. - The company has distributed a total of 1.092 billion CNY in dividends since its A-share listing, with 584 million CNY distributed over the past three years [2]. Group 3: Shareholder Information - As of March 31, 2025, the number of shareholders for Yuyuan Pharmaceutical was 14,700, an increase of 2.50% from the previous period [2]. - The average circulating shares per shareholder were 30,525 shares, a decrease of 2.44% from the previous period [2]. - Among the top ten circulating shareholders, 富国精准医疗灵活配置混合A held 7.501 million shares, a decrease of 1.438 million shares from the previous period [3].